TGFB1 and metabolic syndrome: CSAT+® supplementation to HFHS-fed mice significantly reduced the MetS-induced overexpression of IL-6 (p < 0.01), COX-2 (p < 0.05), MCP-1 (p < 0.05), and TGF-β (p < 0.01).